Single logo
LoginSign Up

Pharmaceutical Pharmacovigilance and Drug Safety Audit Checklist

A comprehensive checklist for auditing pharmacovigilance and drug safety processes in pharmaceutical companies to ensure regulatory compliance, patient safety, and effective risk management.

Pharmaceutical Pharmacovigilance and Drug Safety Audit Checklist

by: audit-now
4.2

Get Template

About This Checklist

Pharmacovigilance is critical in ensuring the ongoing safety of pharmaceutical products post-marketing. This Pharmaceutical Pharmacovigilance and Drug Safety Audit Checklist is a vital tool for evaluating the effectiveness and compliance of pharmacovigilance systems and processes. By systematically assessing adverse event reporting, signal detection, risk management plans, periodic safety update reports, and regulatory communications, this checklist helps maintain robust drug safety monitoring and timely response to emerging safety concerns. Regular implementation of this comprehensive audit process can significantly enhance patient safety, improve regulatory compliance, and support the ongoing benefit-risk assessment of pharmaceutical products throughout their lifecycle.

Learn more

Industry

Healthcare

Standard

Pharmacovigilance Standards

Workspaces

Research Facilities

Occupations

Pharmacovigilance Auditor
Drug Safety Specialist
Regulatory Affairs Manager
Medical Safety Officer
Quality Assurance Manager
1
Is the adverse event reporting process compliant with ICH E2A-E2F and EU GVP guidelines?
2
What is the frequency of signal detection reviews conducted in the last quarter?
Target: 4
3
Please describe the current status of the risk management plan for the drug.
4
When was the last periodic safety update report submitted?
5
Is the safety database management compliant with FDA Pharmacovigilance Guidance?
6
What measures are in place to ensure the accuracy of data entries in the safety database?
7
Describe the process for reviewing incident reports for completeness and accuracy.
8
What is the acceptable error rate for data entry in the safety database?
Target: 2
9
When was the last data quality audit conducted?
10
Are staff members trained regularly on data entry protocols and compliance measures?
11
How frequently are risk assessments conducted for the pharmacovigilance system?
12
What risk mitigation strategies are in place for identified risks?
13
What is the current risk rating for the pharmacovigilance system?
Target: 3
14
When was the last risk assessment conducted?
15
Is the action plan for addressing identified risks currently being implemented?
16
Are regulatory submissions made within the required timeframes as per ICH E2A-E2F guidelines?
17
What records are maintained to ensure staff are trained on regulatory compliance?
18
How often are compliance audits performed on the pharmacovigilance system?
Target: 6
19
When was the last compliance audit conducted?
20
Is there a corrective action plan in place for any recent compliance findings?
21
Is there an established quality assurance program for pharmacovigilance activities?
22
What quality metrics are monitored to evaluate the effectiveness of the pharmacovigilance system?
23
What is the average time taken to resolve quality issues identified in pharmacovigilance?
Target: 10
24
When was the last quality review conducted for pharmacovigilance processes?
25
Are staff members provided with training on quality assurance practices?

FAQs

Comprehensive pharmacovigilance audits should be conducted annually. However, specific processes or high-risk areas may require more frequent audits, and additional audits should be performed following significant changes to the pharmacovigilance system.

This checklist covers adverse event collection and reporting processes, signal detection and evaluation methods, risk management plan implementation, periodic safety update report preparation, literature monitoring, safety database management, and regulatory compliance with global pharmacovigilance requirements.

These audits are typically conducted by qualified pharmacovigilance auditors, drug safety specialists, or quality assurance professionals with expertise in global pharmacovigilance regulations and best practices.

The checklist ensures that all aspects of the pharmacovigilance system meet regulatory requirements, including timely reporting of adverse events, proper signal management, and accurate benefit-risk assessments, which are crucial for maintaining product safety and regulatory compliance.

If significant non-conformities are identified, actions should include immediate assessment of the impact on patient safety, implementation of corrective and preventive measures, potential reporting to regulatory authorities, review of affected processes or products, and enhanced monitoring. All actions must be thoroughly documented and followed up.

Benefits of Pharmaceutical Pharmacovigilance and Drug Safety Audit Checklist

Ensures compliance with global pharmacovigilance regulations and guidelines

Enhances early detection and management of drug safety signals

Improves the quality and timeliness of safety reporting to regulatory authorities

Reduces risks associated with delayed or inadequate safety measures

Facilitates continuous improvement of drug safety monitoring processes